Regina E. Groves's Insider Trades & SAST Disclosures

Regina E. Groves's most recent trade in Atricure Inc was a trade of 5,401 Common Stock done . Disclosure was reported to the exchange on May 19, 2025.

Share

Note

This is a custom search result for pattern Regina E. Groves.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Atricure Inc	Regina E. Groves	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	19 May 2025	5,401	36,167 (0%)	0%		0	Common Stock
Fulgent Genetics Inc	Regina E. Groves	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 May 2025	8,982	16,982 (0%)	0%		0	Common Stock
Fulgent Genetics Inc	Regina E. Groves	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 May 2024	5,481	5,481	-		-	Stock Option (Right to Buy)
Fulgent Genetics Inc	Regina E. Groves	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 May 2024	4,000	8,000 (0%)	0%		0	Common Stock
Atricure Inc	Regina E. Groves	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 May 2024	7,788	30,766 (0%)	0%		0	Common Stock
Atricure Inc	Regina E. Groves	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 May 2023	3,186	22,978 (0%)	0%		0	Common Stock
Fulgent Genetics Inc	Regina E. Groves	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 May 2023	6,759	6,759	-		-	Stock Option (Right to Buy)
Fulgent Genetics Inc	Regina E. Groves	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2023	10,000	10,000	-		-	Stock Option (Right to Buy)
Fulgent Genetics Inc	Regina E. Groves	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2023	4,000	4,000 (0%)	0%		0	Common Stock

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades